Congo, Democratic Republic of the vs Congo: Hepatitis B surface antigen (HBsAg) prevalence
Congo, Democratic Republic of the
1.4%
in 2024
Congo
1.6%
in 2024
Congo, Democratic Republic of the rank
19th
Congo rank
18th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Congo, Democratic Republic of the
- Congo
How they compare
Congo currently reports 1.6% against 1.4% in Congo, Democratic Republic of the, a difference of 0.2%.
That makes Congo's figure about 1.1 times Congo, Democratic Republic of the's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 19th and Congo ranks 18th of 194 countries.
Congo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 1.6% | 0.1% | Congo |
| 2020s | 1.4% | 1.6% | 0.2% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Congo, Democratic Republic of the or Congo?
- Congo, at 1.6% against 1.4% in Congo, Democratic Republic of the as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Congo, Democratic Republic of the and Congo?
- 0.2%, with Congo ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Congo?
- 10 years are reported by both, from 2015 to 2024.
- How do Congo, Democratic Republic of the and Congo rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Congo, Democratic Republic of the ranks 19th and Congo ranks 18th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.